<DOC>
	<DOCNO>NCT00374985</DOCNO>
	<brief_summary>The purpose study determine dose limit toxicity maximum tolerable dose radiochemotherapy Docetaxel Oxaliplatin patient adenocarcinoma gastric-oesophageal junction .</brief_summary>
	<brief_title>Safety Efficacy Neoadjuvant Radiochemotherapy Adenocarcinoma Gastric-oesophageal Junction</brief_title>
	<detailed_description>Radiotherapy start day 1 chemotherapy application Docetaxel Oxaliplatin administer single dos 1.8 Gy daily five time week 5 week . In sixth treatment week boost 3 radiation 1.8 Gy apply . Simultaneous chemotherapy : Initially , part A study maximum tolerable dose ( MTD ) simultaneous chemotherapy identify 3-step dose escalation scheme : Level 1 : Docetaxel : 20 mg/m2 Oxaliplatin 40 mg/m2 i.v. , Level 2 : Docetaxel : 20 mg/m2 Oxaliplatin 50 mg/m2 i.v. , Level 3 : Docetaxel : 25 mg/m2 Oxaliplatin 50 mg/m2 i.v. , The treatment start 3 patient level 1 . If dose limit toxicity appear , switch dose level 2 . The applies switch level 2 level 3 . If DLT appear one level , 3 patient treat within dose level . If one level least 2 6 patient show DLT , subjacent level define maximum tolerable dose ( MTD ) .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>adenocarcinoma gastricesophagal junction stage II III unidimensional measurable disease surgery primary tumor metastasis prior chemo radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>chemoradiation</keyword>
	<keyword>docetaxel</keyword>
	<keyword>oxaliplatin</keyword>
	<keyword>gastric</keyword>
	<keyword>neoadjuvant</keyword>
	<keyword>radiochemotherapy</keyword>
</DOC>